Cargando…

Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi

BACKGROUND: In our previous studies on lipoprotein secretion in the Lyme disease spirochete Borrelia burgdorferi, we used monomeric red fluorescent protein 1 (mRFP1) fused to specifically mutated outer surface protein A (OspA) N-terminal lipopeptides to gather first insights into lipoprotein sorting...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumru, Ozan S, Schulze, Ryan J, Slusser, Joyce G, Zückert, Wolfram R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987989/
https://www.ncbi.nlm.nih.gov/pubmed/21047413
http://dx.doi.org/10.1186/1471-2180-10-277
_version_ 1782192202333552640
author Kumru, Ozan S
Schulze, Ryan J
Slusser, Joyce G
Zückert, Wolfram R
author_facet Kumru, Ozan S
Schulze, Ryan J
Slusser, Joyce G
Zückert, Wolfram R
author_sort Kumru, Ozan S
collection PubMed
description BACKGROUND: In our previous studies on lipoprotein secretion in the Lyme disease spirochete Borrelia burgdorferi, we used monomeric red fluorescent protein 1 (mRFP1) fused to specifically mutated outer surface protein A (OspA) N-terminal lipopeptides to gather first insights into lipoprotein sorting determinants. OspA:mRFP1 fusions could be detected by epifluorescence microscopy both in the periplasm and on the bacterial surface. To build on these findings and to complement the prior targeted mutagenesis approach, we set out to develop a screen to probe a random mutagenesis expression library for mutants expressing differentially localized lipoproteins. RESULTS: A Glu-Asp codon pair in the inner membrane-localized OspA20:mRFP1 fusion was chosen for mutagenesis since the two negative charges were previously shown to define the phenotype. A library of random mutants in the two codons was generated and expressed in B. burgdorferi. In situ surface proteolysis combined with fluorescence activated cell sorting (FACS) was then used to screen for viable spirochetes expressing alternative subsurface OspA:mRFP1 fusions. Analysis of 93 clones randomly picked from a sorted cell population identified a total of 43 distinct mutants. Protein localization assays indicated a significant enrichment in the selected subsurface phenotype. Interestingly, a majority of the subsurface mutant proteins localized to the outer membrane, indicating their impairment in "flipping" through the outer membrane to the spirochetal surface. OspA20:mRFP1 remained the protein most restricted to the inner membrane. CONCLUSIONS: Together, these results validate this FACS-based screen for lipoprotein localization and suggest a rather specific inner membrane retention mechanism involving membrane anchor-proximal negative charge patches in this model B. burgdorferi lipoprotein system.
format Text
id pubmed-2987989
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29879892010-11-19 Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi Kumru, Ozan S Schulze, Ryan J Slusser, Joyce G Zückert, Wolfram R BMC Microbiol Methodology Article BACKGROUND: In our previous studies on lipoprotein secretion in the Lyme disease spirochete Borrelia burgdorferi, we used monomeric red fluorescent protein 1 (mRFP1) fused to specifically mutated outer surface protein A (OspA) N-terminal lipopeptides to gather first insights into lipoprotein sorting determinants. OspA:mRFP1 fusions could be detected by epifluorescence microscopy both in the periplasm and on the bacterial surface. To build on these findings and to complement the prior targeted mutagenesis approach, we set out to develop a screen to probe a random mutagenesis expression library for mutants expressing differentially localized lipoproteins. RESULTS: A Glu-Asp codon pair in the inner membrane-localized OspA20:mRFP1 fusion was chosen for mutagenesis since the two negative charges were previously shown to define the phenotype. A library of random mutants in the two codons was generated and expressed in B. burgdorferi. In situ surface proteolysis combined with fluorescence activated cell sorting (FACS) was then used to screen for viable spirochetes expressing alternative subsurface OspA:mRFP1 fusions. Analysis of 93 clones randomly picked from a sorted cell population identified a total of 43 distinct mutants. Protein localization assays indicated a significant enrichment in the selected subsurface phenotype. Interestingly, a majority of the subsurface mutant proteins localized to the outer membrane, indicating their impairment in "flipping" through the outer membrane to the spirochetal surface. OspA20:mRFP1 remained the protein most restricted to the inner membrane. CONCLUSIONS: Together, these results validate this FACS-based screen for lipoprotein localization and suggest a rather specific inner membrane retention mechanism involving membrane anchor-proximal negative charge patches in this model B. burgdorferi lipoprotein system. BioMed Central 2010-11-03 /pmc/articles/PMC2987989/ /pubmed/21047413 http://dx.doi.org/10.1186/1471-2180-10-277 Text en Copyright ©2010 Kumru et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Kumru, Ozan S
Schulze, Ryan J
Slusser, Joyce G
Zückert, Wolfram R
Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi
title Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi
title_full Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi
title_fullStr Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi
title_full_unstemmed Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi
title_short Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi
title_sort development and validation of a facs-based lipoprotein localization screen in the lyme disease spirochete borrelia burgdorferi
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987989/
https://www.ncbi.nlm.nih.gov/pubmed/21047413
http://dx.doi.org/10.1186/1471-2180-10-277
work_keys_str_mv AT kumruozans developmentandvalidationofafacsbasedlipoproteinlocalizationscreeninthelymediseasespirocheteborreliaburgdorferi
AT schulzeryanj developmentandvalidationofafacsbasedlipoproteinlocalizationscreeninthelymediseasespirocheteborreliaburgdorferi
AT slusserjoyceg developmentandvalidationofafacsbasedlipoproteinlocalizationscreeninthelymediseasespirocheteborreliaburgdorferi
AT zuckertwolframr developmentandvalidationofafacsbasedlipoproteinlocalizationscreeninthelymediseasespirocheteborreliaburgdorferi